Quantinno Capital Management’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
Quantinno Capital Management's ADPT Position: Q3 2026 in Review
Quantinno Capital Management increased its Adaptive Biotechnologies (ADPT) stake by 3.8% in Q3 2026, buying an estimated $44.7K and bringing the position to 49,724 shares worth $1.44M. The position accounts for ﹤0.01% of the portfolio, ranked #2481.
Quantinno Capital Management first reported a position in ADPT in Q4 2024 and has held it in 8 quarters since. 334 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.
- Quantinno Capital Management held 49,724 shares of Adaptive Biotechnologies worth $1.44M as of Q3 2026.
- Quantinno Capital Management bought 1,819 Adaptive Biotechnologies shares in Q3 2026, an estimated $44.7K.
- Adaptive Biotechnologies made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #2481 holding.
- Quantinno Capital Management first reported a position in Adaptive Biotechnologies in Q4 2024 and has held it in 8 quarters since.
- 334 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.
Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.